Which of the following is the primary advantage of a lab on a chip in healthcare?

Get ready for the McClure HSHS Current Issues in Healthcare Test. Study with multiple choice questions, hints, and explanations. Prepare effectively and ace the exam!

Multiple Choice

Which of the following is the primary advantage of a lab on a chip in healthcare?

Explanation:
The main idea is that a lab on a chip brings diagnostic testing to the patient with a compact device that can deliver results quickly. By integrating sample processing, analysis, and detection on a micro-scale platform, these systems enable tests to be done at the point of care—in clinics, emergency departments, or even in field settings—without sending samples to a distant central lab. This portability means clinicians can obtain actionable results much faster, supporting faster decisions, faster treatment initiation, and improved patient flow. While traditional labs offer high throughput, the standout benefit of lab-on-a-chip technology is the ability to perform rapid testing where the patient is, which this option captures. The other ideas describe scenarios that don’t align with this core advantage: higher cost with longer turnaround, the need for large infrastructure, or assays that are inherently less sensitive. In practice, the defining value is fast, accessible results from a portable device.

The main idea is that a lab on a chip brings diagnostic testing to the patient with a compact device that can deliver results quickly. By integrating sample processing, analysis, and detection on a micro-scale platform, these systems enable tests to be done at the point of care—in clinics, emergency departments, or even in field settings—without sending samples to a distant central lab. This portability means clinicians can obtain actionable results much faster, supporting faster decisions, faster treatment initiation, and improved patient flow. While traditional labs offer high throughput, the standout benefit of lab-on-a-chip technology is the ability to perform rapid testing where the patient is, which this option captures. The other ideas describe scenarios that don’t align with this core advantage: higher cost with longer turnaround, the need for large infrastructure, or assays that are inherently less sensitive. In practice, the defining value is fast, accessible results from a portable device.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy